Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
GlobeNewswire
Today at 9:10pm UTC
Equus Announces First Quarter Net Asset Value
GlobeNewswire
Today at 9:07pm UTC
ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action...
GlobeNewswire
Today at 9:06pm UTC
Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of...
GlobeNewswire
Today at 9:06pm UTC
Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload
PR Newswire
Today at 9:05pm UTC
Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid...
GlobeNewswire
Today at 9:05pm UTC
North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders
GlobeNewswire
Today at 9:05pm UTC
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical...
GlobeNewswire
Today at 9:05pm UTC
Imperial Announces Voting Results for the Election of Directors
GlobeNewswire
Today at 9:02pm UTC
/C O R R E C T I O N -- VidantaWorld/
PR Newswire
Today at 9:02pm UTC
Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for...
GlobeNewswire
Today at 9:02pm UTC
/C O R R E C T I O N -- VidantaWorld/
PR Newswire
Today at 9:02pm UTC
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid...
GlobeNewswire
Today at 9:01pm UTC
Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
GlobeNewswire
Today at 9:01pm UTC
ALDX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel...
GlobeNewswire
Today at 9:01pm UTC
Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated...
GlobeNewswire
Today at 9:01pm UTC
AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
GlobeNewswire
Today at 9:00pm UTC
Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
PR Newswire
Today at 9:00pm UTC
Legend Biotech Announces Presentations at ASCO 2026
GlobeNewswire
Today at 9:00pm UTC
Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
PR Newswire
Today at 9:00pm UTC